• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAR 巨噬细胞调节抗肿瘤治疗的免疫交响乐。

CAR macrophages tuning the immune symphony of anti-cancer therapies.

机构信息

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany.

Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany; RESIST, Cluster of Excellence, Hannover Medical School, 30625 Hannover, Germany; Biomedical Research in End Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany; Center of Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, 30625 Hannover, Germany.

出版信息

Cell Stem Cell. 2024 Jun 6;31(6):791-793. doi: 10.1016/j.stem.2024.05.006.

DOI:10.1016/j.stem.2024.05.006
PMID:38848684
Abstract

Chimeric antigen receptor (CAR) macrophages have broadened the landscape of anti-cancer immunotherapies to combat solid malignancies. Shah et al. introduce CARs to facilitate a CAR macrophage therapy, which aims to recruit and activate T/natural killer cells, further strengthening the overall immune response to decrease pancreatic cancer burden and metastatic spreading.

摘要

嵌合抗原受体 (CAR) 巨噬细胞拓宽了抗癌免疫疗法的领域,以对抗实体恶性肿瘤。Shah 等人引入了 CAR 来促进 CAR 巨噬细胞疗法,旨在招募和激活 T/自然杀伤细胞,进一步增强整体免疫反应,以减轻胰腺癌负担和转移扩散。

相似文献

1
CAR macrophages tuning the immune symphony of anti-cancer therapies.CAR 巨噬细胞调节抗肿瘤治疗的免疫交响乐。
Cell Stem Cell. 2024 Jun 6;31(6):791-793. doi: 10.1016/j.stem.2024.05.006.
2
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors.工程化 CAR-巨噬细胞作为实体瘤的过继免疫疗法。
Front Immunol. 2021 Nov 24;12:783305. doi: 10.3389/fimmu.2021.783305. eCollection 2021.
3
CAR-NK Cells: From Natural Basis to Design for Kill.嵌合抗原受体自然杀伤细胞:从天然基础到杀伤设计。
Front Immunol. 2021 Dec 14;12:707542. doi: 10.3389/fimmu.2021.707542. eCollection 2021.
4
CAR T Cells Releasing IL-18 Convert to T-Bet FoxO1 Effectors that Exhibit Augmented Activity against Advanced Solid Tumors.嵌合抗原受体 T 细胞(CAR T 细胞)释放白细胞介素 18 可转化为 T 细胞特异性转录因子(T-Bet)FoxO1 效应物,对晚期实体瘤表现出增强的活性。
Cell Rep. 2017 Dec 12;21(11):3205-3219. doi: 10.1016/j.celrep.2017.11.063.
5
Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy.工程嵌合抗原受体-自然杀伤细胞用于癌症免疫治疗。
Immunotherapy. 2020 Jun;12(9):653-664. doi: 10.2217/imt-2019-0139. Epub 2020 May 21.
6
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer.人源抗 PSCA CAR 巨噬细胞对胰腺癌具有强大的抗肿瘤活性。
Cell Stem Cell. 2024 Jun 6;31(6):803-817.e6. doi: 10.1016/j.stem.2024.03.018. Epub 2024 Apr 24.
7
Editorial: Cancer immunotherapies for hematologic malignancies - NK/CIK/CAR-T perspective.社论:血液系统恶性肿瘤的癌症免疫疗法——自然杀伤细胞/细胞因子诱导的杀伤细胞/嵌合抗原受体T细胞视角
Front Immunol. 2024 Jun 18;15:1434259. doi: 10.3389/fimmu.2024.1434259. eCollection 2024.
8
Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments.嵌合抗原受体免疫细胞治疗实体瘤:结构、机制、最新进展及未来发展。
Chin Med J (Engl). 2024 Jun 5;137(11):1285-1302. doi: 10.1097/CM9.0000000000002818. Epub 2023 Aug 28.
9
Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages.CSF1R 靶向嵌合抗原受体修饰的 NK92MI&T 细胞对肿瘤相关巨噬细胞的影响。
Immunotherapy. 2018 Aug;10(11):935-949. doi: 10.2217/imt-2018-0012.
10
Natural killer cell-related anti-tumour adoptive cell immunotherapy.自然杀伤细胞相关抗肿瘤过继细胞免疫治疗。
J Cell Mol Med. 2024 Jun;28(11):e18362. doi: 10.1111/jcmm.18362.

引用本文的文献

1
Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy.嵌合抗原受体工程化细胞免疫疗法的当前挑战与新出现的机遇
Exp Hematol Oncol. 2025 Jul 2;14(1):92. doi: 10.1186/s40164-025-00683-y.
2
Tonic signaling in CAR-T therapy: the lever long enough to move the planet.嵌合抗原受体T细胞(CAR-T)疗法中的张力信号传导:撬动地球的足够长杠杆。
Front Med. 2025 Mar 21. doi: 10.1007/s11684-025-1130-x.